Tenet Healthcare (THC) Financials

Tenet Healthcare’s recent results show a sharp improvement in reported profitability and a multiyear expansion in revenue, although cash flow softened in the second quarter and leverage remains significant. The latest figures cover the quarter ended June 30, 2026, with certain prior-period results restated, so investors should focus on comparable, restated periods where available.

• Revenue growth has remained consistent. Second-quarter 2026 revenue increased 6.8% year over year to $5.63 billion, up from $5.27 billion in the restated second quarter of 2025 and $5.11 billion in the second quarter of 2024. Revenue was also higher than the $5.37 billion reported in the first quarter of 2026.
• Gross profit and operating profitability improved substantially. Second-quarter gross profit rose 9.2% year over year to $3.40 billion, while operating income increased to $1.50 billion from $823 million. The reported operating margin expanded to approximately 26.7% from 15.6%.
• Common-shareholder earnings and EPS accelerated. Net income attributable to common shareholders increased to $826 million in Q2 2026 from $288 million a year earlier. Diluted EPS rose to $9.84 from $3.14, while diluted shares outstanding declined to 84.0 million from 91.8 million, providing an additional per-share benefit.
• The longer-term earnings trend is favorable. Reported common EPS increased from $1.15 in Q2 2023 to $2.64 in Q2 2024, $3.14 in Q2 2025 and $9.84 in Q2 2026. Although special items affect comparability, the data indicate meaningful improvement from the weaker profitability levels seen in 2022 and 2023.
• First-half cash generation improved year over year. Operating cash flow for the first half of 2026 totaled approximately $2.23 billion, compared with $1.75 billion in the first half of 2025. After capital expenditures, estimated first-half free cash flow increased to roughly $1.88 billion from $1.38 billion.
• Capital spending has been disciplined relative to operating cash flow. Second-quarter capital expenditures declined to $168 million from $193 million in Q2 2025 and $216 million in Q3 2024. The company still generated approximately $417 million of quarterly free cash flow after capital spending.
• Share repurchases are reducing the share count. Tenet repurchased $1.04 billion of common stock in Q2 2026, following $318 million in Q1 and $747 million in Q2 2025. The weighted-average diluted share count has fallen from 104.8 million in Q4 2023 to 84.0 million in Q2 2026, supporting EPS growth for remaining shareholders.
• The balance sheet has expanded while liquidity remains adequate. Total assets reached $30.68 billion in Q2 2026, up from $28.70 billion in Q2 2025. The current ratio improved sequentially to approximately 1.4 times, but remained below the roughly 1.7 times recorded a year earlier. Cash and equivalents stood at $2.17 billion at quarter-end.
• Reported operating income benefited from unusually large special items. Q2 2026 included $443 million of other special income, compared with $66 million of special expense in the restated Q2 2025 period. Excluding the Q2 2026 benefit, operating income would have been approximately $1.06 billion—still higher than the prior-year period, but materially below the reported $1.50 billion.
• Quarterly operating cash flow weakened sharply in Q2. Operating cash flow declined to $585 million from $936 million in Q2 2025. The primary drag was a $648 million use of cash from changes in operating assets and liabilities, compared with a $151 million source of cash a year earlier. This suggests working-capital movements, rather than profitability alone, drove the quarter’s cash-flow decline.
• Cash fell after aggressive capital returns. Cash declined by $797 million during Q2 2026, as $1.04 billion of share repurchases and $210 million of dividends contributed to $1.18 billion of net financing cash outflow. Cash fell from $2.97 billion at the end of Q1 to $2.17 billion at the end of Q2.
• Debt and interest costs remain substantial. Total short- and long-term debt was approximately $13.25 billion in Q2 2026, broadly stable year over year but still high relative to cash. Cash interest paid increased to $341 million in Q2 2026 from $300 million in Q2 2025, and reported interest expense remained above $200 million per quarter.
• Goodwill and noncontrolling interests create balance-sheet sensitivity. Goodwill increased to $11.44 billion, representing a large portion of total assets, while redeemable noncontrolling interest was $2.14 billion and other noncontrolling interest was $1.90 billion. These items can complicate the equity picture and increase sensitivity to impairment charges or changes in subsidiary valuations.

Overall, Tenet’s operating trajectory is stronger than it was several years ago: revenue is growing, margins have expanded, common EPS has benefited from both earnings growth and buybacks, and first-half free cash flow improved. However, investors should distinguish recurring operating performance from special-item gains, monitor working-capital volatility, and weigh the company’s sizable debt burden against its cash-generation capacity.